![United States: Updates On Aflibercept BPCIA Litigation - Goodwin Procter LLP](https://cdn.newsserve.net/ONPglobe256.png)
United States: Updates On Aflibercept BPCIA Litigation - Goodwin Procter LLP
The proposed schedule also provides dates for document discovery and depositions.
Full Article
The proposed schedule also provides dates for document discovery and depositions.
Full ArticleAs we have previously reported, in November 2023 Regeneron Pharmaceuticals, Inc. ("Regeneron") filed complaints against Celltrion,..